
ADC Therapeutics SA
ADCT
ADCT: ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.
moreShow ADCT Financials
Recent trades of ADCT by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ADCT's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on ADCT's company Twitter account
Number of mentions of ADCT in WallStreetBets Daily Discussion
Recent insights relating to ADCT
Recent picks made for ADCT stock on CNBC
ETFs with the largest estimated holdings in ADCT
Flights by private jets registered to ADCT